World Precision Medicine Congress, London, May 2018
WHAT’S IN STORE FOR 2018?
It is clear that no one will succeed in precision medicine alone. Partnerships and
collaborations will be key to advancing this promising sector.
So with that in mind, World Precision Medicine Congress 2018 will bring together
academia, industry and healthcare to discuss and debate key challenges and
Rare diseases and Orphan drugs | Drug discovery and development | Companion Diagnostics | Cancer Genomics | Wearables and Digital Health | Genomic Medicine | Big data and Genomics | Healthcare Track
Industry and thought- leading topics bringing together the whole value chain
• Discover plans to innovate the implementation of precision medicine into clinical practice
• Hear the latest in diagnostics and biomarkers
• Understand how infrastructure and financing are industrialising precision medicine
• Conquer the challenges of big data and genomics
• Learn about the latest in precision oncology and rare diseases as well as other therapy areas
NEW FOR 2018
For the first time, an entire track will be dedicated to the topic of Artificial Intelligence in Healthcare.
In parallel to the strategic conference, an exhibition will gather 80+ companies and hundreds of visitors from pharma and biotech companies as well as academia.
Standard ticket price (early bird price ending 24th February): GBP 2510
Academic price (early bird price ending 24th February): GBP 1125
Speakers: Aarno Palotie, Group Leader, Massachusetts General Hospital, - Aaron Black, Director of Informatics, Inova, - Alain Thierry, Research Director, INSERM, - Ansar Jawaid, Founder and Chief Executive Officer, Precision Medicines, - Anthony Whetton, Director, Stoller Biomarker Discovery Centre, University of Manchester, - Brad Perkins, Chief Medical Officer, Human Longevity, - Cecilia Lindskog Bergstrom, Site Director, Human Protein Atlas, Uppsala University, - Christophe Le Tourneau, Head of Phase I programme and Co-head of the Clinical Trial Unit, Institut Curie, - Clare Turnbull, Senior Researcher in Cancer Genomics, Institute of Cancer Research, - David Pearce, President, Sanford Health, - David Smith, Professor, Mayo Clinic, - Dipak Kalra, President, EuroRec, - Gil Alterovitz, Assistant Professor, Harvard/MIT, - Jacqui Shaw, Professor of Translational Cancer, University of Leicester, - Jan Kuentzer, Head of Data Science Application Services, Roche, - Jane Dunnage, Patient and Public Involvement Lead, Lupus UK, - Janette Rawlinson, Lay Member, CRUK Stratified Medicine Programme, - Jay Goth, Managing Member, Forentis Fund, - Jean-Louis Mandel, Professor of Human Genetics, College de France, University of Strasbourg, - Jeffrey Barrett, Vice President of Interdisciplinary Pharmacometrics Program and Head of Translational Informatics, Sanofi, - Jeff Skopek, Lecturer in Medical Law, Ethics, and Policy, University of Cambridge, - Joanne Mason, Director of Sequencing and Sample Acquisition, Genomics England, - Juergin Eils, Group Leader, German Cancer Research Centre, - Julia Wilson, Associate Director, Wellcome Trust Sanger Institute, - Julien De Salaberry, Managing Director, The Asia HealthTech Connector, - Karen Harrison, Support Services Manager, ADL Life, - Karina Bienfair, Head, Global Genomics Policy, Process and Compliance, MSD (Merck Research Laboratories), - Katherine Payne, Professor of Health Economics, Manchester Centre for Health Economics, The University of Manchester, - Louis Fiore, C.S.P. Director of Bioinformatics, Department of Veterans Association, - Maria Chatzou, Research Bioinformatics Engineer and President, Innovation Forum Barcelona Centre for Genomic Regulation, - Marie-Claire Parker, Business Development Manager, Scottish Stratified Innovation Medical Center, - Marilyn Robertson, Ecosystem Manager, Scottish Stratified Innovation Medical Center, - Melina Kalofonou, Postdoctoral Researcher, Imperial College London, - Nikole Kimes, Co-Founder and Vice President, Siolta Therapeutics, - Pantelis Grorgiou, Senior Lecturer, Imperial College London, - Paul-Peter Tak, Senior Vice President of Research and Development Pipeline, Chief Immunology Officer, GSK, - Ricardo Sabatini, Co-founder, Chief Data Officer, Orionis Biosciences, - Ron Przygodzkiy, Director, Genomic Medicine Implementation, Department of Veterans Association, - Rosemary Barber, Honorary Senior Research Fellow, Public Health, University of Sheffield, - Seshandri Vasan, Senior Business Development Maager, University of York, Public Health England, - Shrikant Mane, Director of Center for Genome Analysis, Yale School of Medicine, - Stephen Deitcher, Chief Executive Officer, Medeor Therapeutics, - Stephen Thomas, Patient Involvement Coach, Cancer Research UK, - Sudhakaran Prabakara, Lecturer, Department of Genetics, Cambridge University, - Sue Hill, Chief Scientific Officer, NHS, - Tony Freemont, Professor of Osteoarticular Pathology, Manchester University
Time: 8:00 am - 6:00 pm
|Event Date: ||16 May 2018 - 18 May 2018
||Contact Person: ||Aurore Colella
|Venue: ||Business Design Centre, London, 52 Upper Street Islington, London, N1 0QH
|Country: ||United Kingdom
Registration Website: http://go.evvnt.com/176257-2?pid=4870
Submitted by Love Evvnt, Evvnt on Wednesday, 16 May 2018 at 8:00 AM
Category: Health Care & Medical